查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1595082

有机药用辅料市场：按功能、形状和产品分类 - 全球预测 2025-2030

Organic Pharmaceutical Excipients Market by Function (Binders, Coating Agents, Colorants), Form (Oral Formulations, Parenteral Formulations, Topical Formulations), Product - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年有机药用辅料市场价值为114.1亿美元，预计到2024年将达到125.2亿美元，复合年增长率为9.81%，到2030年将达到219.9亿美元。

有机药用辅料市场因其在药物配方和药物输送系统中的重要作用而受到关注。这些赋形剂主要是天然衍生的非活性成分，用于促进药物製造过程并提高患者的可接受性。他们的需求源于其提高药物生物有效性、稳定性和控制释放的能力，这使得它们在药品製造中至关重要。它应用于锭剂、胶囊、注射剂等多种剂型，其最终用途主要在製药领域，如学名药製造和创新药物开发。关键的成长要素包括快速成长的製药业、药物传递技术的进步以及对天然和无毒赋形剂选择的日益偏好。成长机会也存在于赋形剂个人化领域，以定製药物输送和优化功能，以及学名药生产不断增长的新兴市场。公司应专注于投资永续采购和创新，以满足严格的监管标准，同时保持成本效益。然而，监管障碍、批次不一致和研发成本上升等挑战可能会阻碍市场进步。透过强有力的合规策略和对先进製造技术的投资来解决这些限制至关重要。此外，创新领域包括开发多功能赋形剂，以提高溶解度和稳定性并减少生态足迹。製药公司和研究机构之间的合作可以促进新辅料的开发。作为一个竞争激烈且不断成长的市场，随着消费者和监管要求的发展，市场扩张潜力巨大。透过研究主导的策略和适应性产品提供领先的公司将获得显着的收益。因此，透过加强策略联盟并专注于永续创新，我们可以释放有机药用辅料领域的巨大市场潜力。

主要市场统计
基准年[2023] 114.1亿美元
预测年份 [2024] 125.2亿美元
预测年份 [2030] 219.9亿美元
复合年增长率（%） 9.81%

市场动态：快速发展的有机药用辅料市场的关键市场洞察

供需的动态交互作用正在改变有机药用辅料市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 有机医药原料需求增加背景下医药产业的成长
    • 学名药、生物相似药和生物製药的需求快速成长
    • 有机医药原料有吸引力的投资
  • 市场限制因素
    • 法规结构的变化
    • 原物料价格波动
  • 市场机会
    • 多功能赋形剂的潜力不断增加
    • 改善有机药品生产
  • 市场挑战
    • 安全和品质问题

波特五力战略工具驾驭有机药用辅料市场

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解有机药用辅料市场的外部影响

外部宏观环境因素在塑造有机药用辅料市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解有机药用辅料市场的竞争状况

对有机药用辅料市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵有机药用辅料市场供应商的绩效评估

FPNV定位矩阵是评估有机药用辅料市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了有机药用辅料市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对有机药用辅料市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对有机医药原料的需求不断增长支持医药产业的成长
      • 学名药、生物相似药和生物製药的需求快速成长
      • 有机医药原料有吸引力的投资
    • 抑制因素
      • 法规结构的变化
      • 原物料价格波动
    • 机会
      • 扩大多功能赋形剂的潜力
      • 改善有机药品生产
    • 任务
      • 安全和品质问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章有机药用辅料市场：依功能

  • 活页夹
  • 被覆剂
  • 着色剂
  • 崩坏
  • 乳化剂
  • 填充剂和稀释剂
  • 调味剂/甜味剂
  • 润滑剂和润滑剂
  • 防腐剂
  • 悬浮剂和黏稠剂

第七章有机药用辅料市场：依形式

  • 口服製剂
    • 胶囊
      • 硬明胶胶囊
      • 软明胶胶囊
    • 液体配方
    • 药片
  • 肠外製剂
  • 局部製剂

第八章有机药用辅料市场：副产品

  • 碳水化合物
    • 纤维素
      • 纤维素酯
      • 纤维素醚
      • CMC和交联羧甲基纤维素钠
      • 结晶纤维素
    • 淀粉
      • 变性淀粉
      • 干淀粉
      • 改质淀粉
    • 醣类
      • 实际含糖量
      • 人工甜味剂
      • 糖醇
  • 油脂化学品
    • 脂醇类
    • 甘油
    • 矿物硬脂酸盐
      • 矿物油
      • 矿物蜡
      • 凡士林
  • 石化产品
    • 丙烯酸聚合物
    • 乙二醇
      • 聚乙二醇
      • 丙二醇
    • 矿物碳氢化合物
    • 聚维酮
  • 蛋白质

第九章美洲有机药用辅料市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太有机药用辅料市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲有机药用辅料市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • ADM Germany GmbH
  • BASF SE
  • Cargill Inc.
  • Croda International Plc
  • DuPont de Nemours, Inc.
  • Evonik Industries AG
  • FMC Corporation
  • Innophos Holdings, Inc.
  • Kerry Group plc
  • Merck KGaA
  • Roquette Freres SA
  • SILVERLINE CHEMICALS LTD.
  • The Lubrizol Corporation
  • The Procter & Gamble Company
  • Wacker Chemie AG
Product Code: MRR-433BAD49EDB9

The Organic Pharmaceutical Excipients Market was valued at USD 11.41 billion in 2023, expected to reach USD 12.52 billion in 2024, and is projected to grow at a CAGR of 9.81%, to USD 21.99 billion by 2030.

The market for organic pharmaceutical excipients is gaining traction due to their critical role in drug formulation and delivery systems. These excipients are non-active constituents, mainly derived from natural sources, used to facilitate the drug manufacturing process and enhance patient acceptability. Their necessity stems from their ability to improve the drug's bioavailability, stability, and controlled release, making them indispensable in pharmaceutical production. They are applied across various formulations, including tablets, capsules, and injectables, with end-use primarily in pharma sectors like generic drug manufacturing and innovative drug development. Key growth factors include the burgeoning pharmaceutical industry, advancements in drug delivery technology, and a rising preference for natural and non-toxic excipient options. Opportunities for growth exist in personalizing excipients to tailor drug delivery and optimize functionality, as well as in emerging markets where generic drug production is on the rise. Companies should focus on sustainable sourcing and investing in innovation to meet stringent regulatory standards while maintaining cost efficiency. However, challenges such as regulatory hurdles, batch inconsistencies, and high R&D costs could impede market progression. Addressing these limitations through robust compliance strategies and investing in advanced manufacturing technologies is crucial. Furthermore, areas for innovation include developing multifunctional excipients that offer enhanced solubility and stability, alongside a reduced ecological footprint. Collaborations between pharmaceutical companies and research institutes can foster novel excipient development. Given its competitive and growing nature, the market offers vast potential for expansion as consumer and regulatory demands evolve. Companies that stay ahead with research-driven strategies and adaptable product offerings stand poised to benefit significantly. Therefore, enhancing strategic alliances and focusing on sustainable innovation can unlock immense market potential in the realm of organic pharmaceutical excipients.

KEY MARKET STATISTICS
Base Year [2023] USD 11.41 billion
Estimated Year [2024] USD 12.52 billion
Forecast Year [2030] USD 21.99 billion
CAGR (%) 9.81%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Organic Pharmaceutical Excipients Market

The Organic Pharmaceutical Excipients Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing pharmaceutical industry backed by the rising demand for organic pharmaceutical ingredients
    • Surge in demand for generic drugs, biosimilars, and biopharmaceuticals
    • Attractive investments in the organic pharmaceutical ingredients
  • Market Restraints
    • Changing regulatory framework
    • Fluctuating prices of raw materials
  • Market Opportunities
    • Growing potential of multifunctional excipients
    • improvements in organic pharmaceutical manufacturing
  • Market Challenges
    • Safety and quality concerns

Porter's Five Forces: A Strategic Tool for Navigating the Organic Pharmaceutical Excipients Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Organic Pharmaceutical Excipients Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Organic Pharmaceutical Excipients Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Organic Pharmaceutical Excipients Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Organic Pharmaceutical Excipients Market

A detailed market share analysis in the Organic Pharmaceutical Excipients Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Organic Pharmaceutical Excipients Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Organic Pharmaceutical Excipients Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Organic Pharmaceutical Excipients Market

A strategic analysis of the Organic Pharmaceutical Excipients Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Organic Pharmaceutical Excipients Market, highlighting leading vendors and their innovative profiles. These include ADM Germany GmbH, BASF SE, Cargill Inc., Croda International Plc, DuPont de Nemours, Inc., Evonik Industries AG, FMC Corporation, Innophos Holdings, Inc., Kerry Group plc, Merck KGaA, Roquette Freres S.A., SILVERLINE CHEMICALS LTD., The Lubrizol Corporation, The Procter & Gamble Company, and Wacker Chemie AG.

Market Segmentation & Coverage

This research report categorizes the Organic Pharmaceutical Excipients Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Function, market is studied across Binders, Coating Agents, Colorants, Disintegrants, Emulsifying Agents, Fillers & Diluents, Flavoring Agents & Sweeteners, Lubricants & Glidants, Preservatives, and Suspending & Viscosity Agents.
  • Based on Form, market is studied across Oral Formulations, Parenteral Formulations, and Topical Formulations. The Oral Formulations is further studied across Capsules, Liquid Formulation, and Tablets. The Capsules is further studied across Hard Gelatin Capsules and Soft Gelatin Capsules.
  • Based on Product, market is studied across Carbohydrates, Oleochemicals, Petrochemicals, and Proteins. The Carbohydrates is further studied across Cellulose, Starch, and Sugars. The Cellulose is further studied across Cellulose Esters, Cellulose Ethers, CMC & Croscarmellose Sodium, and Microcrystalline Cellulose. The Starch is further studied across Converted Starch, Dried Starch, and Modified Starch. The Sugars is further studied across Actual Sugars, Artificial Sweeteners, and Sugar Alcohols. The Oleochemicals is further studied across Fatty Alcohols, Glycerin, and Mineral Stearates. The Mineral Stearates is further studied across Mineral Oils, Mineral Waxes, and Petrolatum. The Petrochemicals is further studied across Acrylic Polymers, Glycols, Mineral Hydrocarbons, and Povidones. The Glycols is further studied across Polyethylene Glycol and Propylene Glycol.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing pharmaceutical industry backed by the rising demand for organic pharmaceutical ingredients
      • 5.1.1.2. Surge in demand for generic drugs, biosimilars, and biopharmaceuticals
      • 5.1.1.3. Attractive investments in the organic pharmaceutical ingredients
    • 5.1.2. Restraints
      • 5.1.2.1. Changing regulatory framework
      • 5.1.2.2. Fluctuating prices of raw materials
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing potential of multifunctional excipients
      • 5.1.3.2. improvements in organic pharmaceutical manufacturing
    • 5.1.4. Challenges
      • 5.1.4.1. Safety and quality concerns
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Organic Pharmaceutical Excipients Market, by Function

  • 6.1. Introduction
  • 6.2. Binders
  • 6.3. Coating Agents
  • 6.4. Colorants
  • 6.5. Disintegrants
  • 6.6. Emulsifying Agents
  • 6.7. Fillers & Diluents
  • 6.8. Flavoring Agents & Sweeteners
  • 6.9. Lubricants & Glidants
  • 6.10. Preservatives
  • 6.11. Suspending & Viscosity Agents

7. Organic Pharmaceutical Excipients Market, by Form

  • 7.1. Introduction
  • 7.2. Oral Formulations
    • 7.2.1. Capsules
      • 7.2.1.1. Hard Gelatin Capsules
      • 7.2.1.2. Soft Gelatin Capsules
    • 7.2.2. Liquid Formulation
    • 7.2.3. Tablets
  • 7.3. Parenteral Formulations
  • 7.4. Topical Formulations

8. Organic Pharmaceutical Excipients Market, by Product

  • 8.1. Introduction
  • 8.2. Carbohydrates
    • 8.2.1. Cellulose
      • 8.2.1.1. Cellulose Esters
      • 8.2.1.2. Cellulose Ethers
      • 8.2.1.3. CMC & Croscarmellose Sodium
      • 8.2.1.4. Microcrystalline Cellulose
    • 8.2.2. Starch
      • 8.2.2.1. Converted Starch
      • 8.2.2.2. Dried Starch
      • 8.2.2.3. Modified Starch
    • 8.2.3. Sugars
      • 8.2.3.1. Actual Sugars
      • 8.2.3.2. Artificial Sweeteners
      • 8.2.3.3. Sugar Alcohols
  • 8.3. Oleochemicals
    • 8.3.1. Fatty Alcohols
    • 8.3.2. Glycerin
    • 8.3.3. Mineral Stearates
      • 8.3.3.1. Mineral Oils
      • 8.3.3.2. Mineral Waxes
      • 8.3.3.3. Petrolatum
  • 8.4. Petrochemicals
    • 8.4.1. Acrylic Polymers
    • 8.4.2. Glycols
      • 8.4.2.1. Polyethylene Glycol
      • 8.4.2.2. Propylene Glycol
    • 8.4.3. Mineral Hydrocarbons
    • 8.4.4. Povidones
  • 8.5. Proteins

9. Americas Organic Pharmaceutical Excipients Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Organic Pharmaceutical Excipients Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Organic Pharmaceutical Excipients Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. ADM Germany GmbH
  • 2. BASF SE
  • 3. Cargill Inc.
  • 4. Croda International Plc
  • 5. DuPont de Nemours, Inc.
  • 6. Evonik Industries AG
  • 7. FMC Corporation
  • 8. Innophos Holdings, Inc.
  • 9. Kerry Group plc
  • 10. Merck KGaA
  • 11. Roquette Freres S.A.
  • 12. SILVERLINE CHEMICALS LTD.
  • 13. The Lubrizol Corporation
  • 14. The Procter & Gamble Company
  • 15. Wacker Chemie AG

LIST OF FIGURES

  • FIGURE 1. ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET RESEARCH PROCESS
  • FIGURE 2. ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET DYNAMICS
  • TABLE 7. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATING AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COLORANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISINTEGRANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY EMULSIFYING AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FILLERS & DILUENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FLAVORING AGENTS & SWEETENERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRESERVATIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY HARD GELATIN CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOFT GELATIN CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LIQUID FORMULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PARENTERAL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE ESTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE ETHERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CMC & CROSCARMELLOSE SODIUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MICROCRYSTALLINE CELLULOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONVERTED STARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DRIED STARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MODIFIED STARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ACTUAL SUGARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ARTIFICIAL SWEETENERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGAR ALCOHOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FATTY ALCOHOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCERIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL OILS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL WAXES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROLATUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ACRYLIC POLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 60. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYETHYLENE GLYCOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 61. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PROPYLENE GLYCOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 62. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 63. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL HYDROCARBONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 64. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POVIDONES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 65. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 66. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 68. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 69. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 70. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 71. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 73. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 74. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 75. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 76. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 77. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 78. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 79. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 80. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 82. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 83. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 84. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 85. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 87. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 88. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 89. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 90. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 91. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 92. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 93. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 94. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 95. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 96. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 97. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 98. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 100. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 101. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 102. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 103. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 104. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 105. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 106. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 107. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 108. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 109. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 110. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 111. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 113. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 114. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 115. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 116. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 117. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 118. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 119. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 120. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 121. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 122. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 123. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 124. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 126. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 127. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 128. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 129. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 130. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 131. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 132. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 133. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 134. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 135. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 136. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 161. AUSTRALIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 162. AUSTRALIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 163. AUSTRALIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 164. AUSTRALIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 165. AUSTRALIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. AUSTRALIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 167. AUSTRALIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 168. AUSTRALIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 169. AUSTRALIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 170. AUSTRALIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 171. AUSTRALIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 172. AUSTRALIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 173. AUSTRALIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 174. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 175. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 176. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 177. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 178. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 180. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 181. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 182. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 183. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 184. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 185. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 186. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 187. INDIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 188. INDIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 189. INDIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 190. INDIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 191. INDIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. INDIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 193. INDIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 194. INDIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 195. INDIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 196. INDIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 197. INDIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 198. INDIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 199. INDIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 200. INDONESIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 201. INDONESIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 202. INDONESIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 203. INDONESIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 204. INDONESIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. INDONESIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 206. INDONESIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 207. INDONESIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 208. INDONESIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 209. INDONESIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 210. INDONESIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 211. INDONESIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 212. INDONESIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 213. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 214. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 215. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 216. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 217. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 219. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 220. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 221. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 222. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 223. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 224. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 225. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 226. MALAYSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 227. MALAYSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 228. MALAYSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 229. MALAYSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 230. MALAYSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. MALAYSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 232. MALAYSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 233. MALAYSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 234. MALAYSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 235. MALAYSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 236. MALAYSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 237. MALAYSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 238. MALAYSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 239. PHILIPPINES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 240. PHILIPPINES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 241. PHILIPPINES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 242. PHILIPPINES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 243. PHILIPPINES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 244. PHILIPPINES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 245. PHILIPPINES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 246. PHILIPPINES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 247. PHILIPPINES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 248. PHILIPPINES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 249. PHILIPPINES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 250. PHILIPPINES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 251. PHILIPPINES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 252. SINGAPORE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 253. SINGAPORE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 254. SINGAPORE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 255. SINGAPORE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 256. SINGAPORE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 257. SINGAPORE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 258. SINGAPORE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 259. SINGAPORE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 260. SINGAPORE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 261. SINGAPORE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 262. SINGAPORE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 263. SINGAPORE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 264. SINGAPORE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 265. SOUTH KOREA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 266. SOUTH KOREA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 267. SOUTH KOREA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 268. SOUTH KOREA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 269. SOUTH KOREA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 270. SOUTH KOREA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 271. SOUTH KOREA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 272. SOUTH KOREA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 273. SOUTH KOREA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 274. SOUTH KOREA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 275. SOUTH KOREA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH KOREA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH KOREA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 278. TAIWAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 279. TAIWAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 280. TAIWAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 281. TAIWAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 282. TAIWAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 283. TAIWAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 284. TAIWAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 285. TAIWAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 286. TAIWAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 287. TAIWAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 288. TAIWAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 289. TAIWAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 290. TAIWAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 291. THAILAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 292. THAILAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 293. THAILAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 294. THAILAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 295. THAILAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 296. THAILAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 297. THAILAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 298. THAILAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 299. THAILAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 300. THAILAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 301. THAILAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 302. THAILAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 303. THAILAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 304. VIETNAM ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 305. VIETNAM ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 306. VIETNAM ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET S